We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.25%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$1.01B
AUM Growth
+$295M
Cap. Flow
+$295M
Cap. Flow %
29.1%
Top 10 Hldgs %
13.6%
Holding
464
New
106
Increased
170
Reduced
65
Closed
115

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
2
IBM icon
IBM
IBM
+$9.84M
3
BIIB icon
Biogen
BIIB
+$9.71M
4
EBAY icon
eBay
EBAY
+$9.47M
5
AAPL icon
Apple
AAPL
+$8.36M

Top Sells

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$5.02M
2
WFC icon
Wells Fargo
WFC
+$4.75M
3
CHSP
Chesapeake Lodging Trust
CHSP
+$4.55M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.34M
5
QCOM icon
Qualcomm
QCOM
+$4.2M

Sector Composition

Rank Sector Weight
1 Financials 15.35%
2 Healthcare 14.47%
3 Technology 13.09%
4 Consumer Discretionary 12.23%
5 Industrials 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGA icon
151
Reinsurance Group of America
RGA
$15.5B
$2.27M 0.22%
23,905
-827
-3% -$77.8K
HAS icon
152
Hasbro
HAS
$12.9B
$2.23M 0.22%
+29,883
New +$2.13M
GTS
153
DELISTED
Triple-S Management Corporation
GTS
$2.23M 0.22%
91,417
+10,701
+13% +$227K
ISEE
154
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.21M 0.22%
+42,370
New +$2.11M
INOV
155
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$2.19M 0.22%
+78,530
New +$2.11M
XLNX
156
DELISTED
Xilinx Inc
XLNX
$2.18M 0.22%
+49,441
New +$2.23M
LUMO
157
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.17M 0.21%
5,457
+3,030
+125% +$1.29M
RKT
158
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$2.17M 0.21%
36,074
+10,987
+44% +$694K
LMT icon
159
Lockheed Martin
LMT
$133B
$2.16M 0.21%
11,629
+374
+3% +$72K
MAR icon
160
Marriott International
MAR
$94.2B
$2.15M 0.21%
28,829
+5,512
+24% +$436K
SCMP
161
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$2.15M 0.21%
130,570
+2,440
+2% +$42.3K
CAR icon
162
Avis
CAR
$4.9B
$2.14M 0.21%
48,503
+1,952
+4% +$103K
PAYX icon
163
Paychex
PAYX
$42.1B
$2.12M 0.21%
45,112
+4,171
+10% +$204K
NXGN
164
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$2.1M 0.21%
126,946
– –
SYKE
165
DELISTED
SYKES Enterprises Inc
SYKE
$2.1M 0.21%
86,550
+28,470
+49% +$704K
PMC
166
DELISTED
PharMerica Corporation
PMC
$2.09M 0.21%
+62,760
New +$1.93M
WMT icon
167
Walmart Inc
WMT
$894B
$2.09M 0.21%
88,359
+2,565
+3% +$65.4K
EBS icon
168
Emergent Biosolutions
EBS
$389M
$2.05M 0.2%
+62,218
New +$1.93M
PDLI
169
DELISTED
PDL BioPharma, Inc.
PDLI
$2.04M 0.2%
317,236
+117,616
+59% +$788K
PG icon
170
Procter & Gamble
PG
$342B
$2.03M 0.2%
26,001
-20,228
-44% -$1.63M
SAM icon
171
Boston Beer
SAM
$1.92B
$2.03M 0.2%
+8,760
New +$2.25M
TWOU
172
DELISTED
2U Inc
TWOU
$2.01M 0.2%
2,084
+1,618
+347% +$1.34M
SONC
173
DELISTED
Sonic Corp
SONC
$2.01M 0.2%
69,780
+3,145
+5% +$96.6K
ATVI
174
DELISTED
Activision Blizzard
ATVI
$2M 0.2%
+82,524
New +$2.01M
ARRY
175
DELISTED
Array Biopharma Inc
ARRY
$2M 0.2%
+276,994
New +$2.04M
5 6
7
8 9

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return

Convergence Investment Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Convergence Investment Partners held 464 positions worth $1.01B, up 41% from $720M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Convergence Investment Partners deployed $295M of net new capital in Q2 2015, opening 106 new positions and adding to 170 existing holdings. Its largest new stake was Biogen: 24,201 shares worth $9.78M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Wells Fargo, an estimated $4.75M trimmed.

  • Convergence Investment Partners's largest Q2 2015 buy was Biogen: 24,201 shares worth $9.78M.
  • Convergence Investment Partners added most to Alphabet (Google) Class C in Q2 2015, an estimated $10.8M increase.
  • Convergence Investment Partners's biggest Q2 2015 reduction was Wells Fargo, cutting an estimated $4.75M.
  • Convergence Investment Partners fully exited Wellcare Health Plans, Inc. in Q2 2015, selling an estimated $5.02M.
  • Convergence Investment Partners's ten largest holdings make up 14% of its $1.01B portfolio in Q2 2015.
  • Convergence Investment Partners opened 106 new positions and closed 115 in Q2 2015.
  • Convergence Investment Partners's portfolio value rose 41% quarter-over-quarter to $1.01B.

Based on Convergence Investment Partners's 13F filing for Q2 2015, filed 5 Aug 2015.